IL131864A0 - Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist - Google Patents

Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

Info

Publication number
IL131864A0
IL131864A0 IL13186499A IL13186499A IL131864A0 IL 131864 A0 IL131864 A0 IL 131864A0 IL 13186499 A IL13186499 A IL 13186499A IL 13186499 A IL13186499 A IL 13186499A IL 131864 A0 IL131864 A0 IL 131864A0
Authority
IL
Israel
Prior art keywords
antagonist
pharmaceutical compositions
receptor agonist
adenosine receptor
adenosine
Prior art date
Application number
IL13186499A
Original Assignee
Can Fite Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Can Fite Technologies Ltd filed Critical Can Fite Technologies Ltd
Priority to IL13186499A priority Critical patent/IL131864A0/en
Priority to IL13368099A priority patent/IL133680A0/en
Priority to ES00956773T priority patent/ES2296637T3/en
Priority to KR1020067006473A priority patent/KR100674529B1/en
Priority to JP2001522994A priority patent/JP4980530B2/en
Priority to PT00956773T priority patent/PT1261322E/en
Priority to PCT/IL2000/000550 priority patent/WO2001019360A2/en
Priority to RU2002109228/15A priority patent/RU2239455C2/en
Priority to CNB008148007A priority patent/CN100358512C/en
Priority to EP00956773A priority patent/EP1261322B1/en
Priority to CA002384111A priority patent/CA2384111C/en
Priority to DE60037277T priority patent/DE60037277T2/en
Priority to MXPA02002546A priority patent/MXPA02002546A/en
Priority to HU0203870A priority patent/HU226913B1/en
Priority to PL356469A priority patent/PL199852B1/en
Priority to CNA2007101850427A priority patent/CN101164548A/en
Priority to US09/700,751 priority patent/US7064112B1/en
Priority to AU68634/00A priority patent/AU782826B2/en
Priority to KR1020027003164A priority patent/KR100584797B1/en
Priority to DK00956773T priority patent/DK1261322T3/en
Priority to BR0013905-0A priority patent/BR0013905A/en
Publication of IL131864A0 publication Critical patent/IL131864A0/en
Priority to HK03105018.4A priority patent/HK1052653B/en
Priority to US11/286,376 priority patent/US20060084626A1/en
Priority to JP2007128137A priority patent/JP2007204496A/en

Links

IL13186499A 1999-09-10 1999-09-10 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist IL131864A0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
IL13186499A IL131864A0 (en) 1999-09-10 1999-09-10 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
IL13368099A IL133680A0 (en) 1999-09-10 1999-12-23 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
DE60037277T DE60037277T2 (en) 1999-09-10 2000-09-08 ADENOSINE RECEPTOR AGONIST OR ANTAGONIST-CONTAINING PHARMACEUTICAL COMPOSITIONS
HU0203870A HU226913B1 (en) 1999-09-10 2000-09-08 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
JP2001522994A JP4980530B2 (en) 1999-09-10 2000-09-08 Pharmaceutical composition comprising an adenosine receptor agonist or antagonist
PT00956773T PT1261322E (en) 1999-09-10 2000-09-08 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
PCT/IL2000/000550 WO2001019360A2 (en) 1999-09-10 2000-09-08 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
RU2002109228/15A RU2239455C2 (en) 1999-09-10 2000-09-08 Pharmaceutical compositions containing agonist or antagonist of adenosine receptor
CNB008148007A CN100358512C (en) 1999-09-10 2000-09-08 Pharmaceutical compositions comprising adenosine receptor agonist or antagonist
EP00956773A EP1261322B1 (en) 1999-09-10 2000-09-08 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
CA002384111A CA2384111C (en) 1999-09-10 2000-09-08 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
ES00956773T ES2296637T3 (en) 1999-09-10 2000-09-08 PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTAGONIST OR AN ADENOSINE RECEIVER AGONIST.
MXPA02002546A MXPA02002546A (en) 1999-09-10 2000-09-08 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist.
KR1020067006473A KR100674529B1 (en) 1999-09-10 2000-09-08 Pharmaceutical Compositions Comprising an Adenosine Receptor Agonist or Antagonist
PL356469A PL199852B1 (en) 1999-09-10 2000-09-08 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
CNA2007101850427A CN101164548A (en) 1999-09-10 2000-09-08 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
US09/700,751 US7064112B1 (en) 1999-09-10 2000-09-08 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
AU68634/00A AU782826B2 (en) 1999-09-10 2000-09-08 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
KR1020027003164A KR100584797B1 (en) 1999-09-10 2000-09-08 Pharmaceutical Compositions Comprising an Adenosine Receptor Agonist or Antagonist
DK00956773T DK1261322T3 (en) 1999-09-10 2000-09-08 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
BR0013905-0A BR0013905A (en) 1999-09-10 2000-09-08 Use of an active ingredient, pharmaceutical composition, methods for inducing g-csf secretion within an individual's body for therapeutic treatment, for inducing proliferation or differentiation of bone marrow or white blood cells in an individual for prevention or treatment. leukopenia, for the prevention or treatment of toxic side effects of a drug, to inhibit abnormal cell growth, to treat cancer, and to use a3rag
HK03105018.4A HK1052653B (en) 1999-09-10 2003-07-11 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
US11/286,376 US20060084626A1 (en) 1999-09-10 2005-11-25 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
JP2007128137A JP2007204496A (en) 1999-09-10 2007-05-14 Pharmaceutical compositions comprising adenosine receptor agonist or antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13186499A IL131864A0 (en) 1999-09-10 1999-09-10 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

Publications (1)

Publication Number Publication Date
IL131864A0 true IL131864A0 (en) 2001-03-19

Family

ID=11073243

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13186499A IL131864A0 (en) 1999-09-10 1999-09-10 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

Country Status (2)

Country Link
CN (1) CN101164548A (en)
IL (1) IL131864A0 (en)

Also Published As

Publication number Publication date
CN101164548A (en) 2008-04-23

Similar Documents

Publication Publication Date Title
HK1052653A1 (en) Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
HUP0203638A3 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them and their use
HUP0201545A2 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them
AU1845402A (en) Nmda receptor agonist pharmaceutical compositions
HUP0401437A3 (en) Adenosine a3 receptor agonists
PT1192169E (en) A2A RECEPTOR AGONIST C-PYRAZOLES
IS5706A (en) Adenosine A3 receptor antagonists
EP1187614A4 (en) Substituted piperidines as melanocortin-4 receptor agonists
HK1049007B (en) Adenosine a2a receptor antagonists
IL142958A0 (en) Vitronectin receptor antagonist pharmaceuticals
EG24194A (en) 5ht-a-partial agonist pharmaceutical compositions
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
IL160715A0 (en) Pharmaceutical compositions containing an a1 adenosine receptor antagonist
HUP0201300A3 (en) Il-8 receptor antagonist imidazoidinylidene-2-imino derivatives and pharmaceutical compositions containing them
EG24025A (en) Vitronectin receptor antagonist
HUP0203603A3 (en) Novel il-8 receptor antagonist indole derivatives and pharmaceutical compositions containing them
AU4980999A (en) A3 adenosine receptor antagonists
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
HUP0200057A2 (en) Dopamine d1 receptor agonist compounds, pharmaceutical compositions containing them and their use
IL131864A0 (en) Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
AU2002302774A1 (en) Macrophage receptor agonist or antagonist
SI1347760T1 (en) Nmda receptor agonist pharmaceutical compositions
IL165716A0 (en) Pharmaceutical compositions containing heterocyclic adenosine receptor antagonists
HU0800727D0 (en) Pharmaceutical composition containing opioid agonistand antagonist combination
GB0015901D0 (en) Compositions containing 5ht receptor agonists